DE:6IRA Stock Latest News
Company AnnouncementsIRLAB Reports Nine-Month Results and Appoints New Chairman6d ago
Company AnnouncementsIRLAB Shifts Focus to Commercializing Existing Drug Portfolio1w ago
Company AnnouncementsIRLAB Announces Q3 2026 Report Presentation and Webcast1w ago
Company AnnouncementsIRLAB Wins Key U.S. Patent Boost for Next-Generation Parkinson’s Drug IRL11173w ago
Company AnnouncementsIRLAB names nomination committee ahead of 2027 AGM1M ago
Company AnnouncementsIRLAB Research on Potential First-in-Class Apathy Drug Linepemat Published1M agoCompany AnnouncementsIRLAB Therapeutics Names Janne Backman as Chairman to Steer Parkinson’s Pipeline and Partnerships1M ago
Company AnnouncementsIRLAB CEO to Step Down in 2027 as Parkinson’s Pipeline Advances2M ago
Company AnnouncementsIRLAB Therapeutics Updates Share Capital After Completed Rights Issue2M ago
Company AnnouncementsIRLAB strengthens Parkinson’s pipeline and finances in Q2 20262M ago
Company AnnouncementsIRLAB to Webcast Q2 2026 Interim Report as Parkinson’s Pipeline Advances3M ago
Company AnnouncementsWHO Grants INN Name to IRLAB’s Apathy Drug Candidate Linepemat3M agoCompany AnnouncementsIRLAB Updates Share Capital After Rights Issue to Support Parkinson’s Pipeline3M ago
Company AnnouncementsIRLAB Therapeutics AGM Confirms No Dividend and New Director Incentives4M ago
Company AnnouncementsIRLAB Raises SEK 76.5 Million in Oversubscribed Rights and Overallotment Issues4M ago
Company AnnouncementsIRLAB’s Mesdopetam Shows Robust Phase II Efficacy in Integrated Analysis Ahead of Partnering Talks5M ago
Company AnnouncementsIRLAB launches largely underwritten SEK 68 million rights issue5M ago
Company AnnouncementsIRLAB Secures Strong Backing for SEK 68 Million Rights Issue5M agoCompany AnnouncementsIRLAB Shareholders Approve New Share Issues and Elect Two New Board Members5M ago




